cancer-patients / English

add

Taylor Swift is making a big impact on a deserving family.

The centre provides services to more than 35,000 patients a year

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes giredestrant, a novel, next-generation…

SAN FRANCISCO, Oct. 18, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (("Olema" or "Olema Oncology", NASDAQ:OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted…

A cancer patient has vowed to “put smiles on children’s faces” with the support of his Wolverhampton football club by organising a toy appeal for youngsters in a city hospital.

The pop star also left the young cancer patient a heartwarming, personalized message on her GoFundMe page.

(MedPage Today) -- BERLIN -- Adding durvalumab (Imfinzi) to bacillus Calmette-Guérin (BCG) induction and maintenance therapy significantly improved disease-free survival (DFS) in patients with BCG-naive, high-risk non-muscle-invasive…

(MedPage Today) -- BERLIN -- In a global phase III trial, the addition of durvalumab (Imfinzi) to standard chemotherapy given before and after surgery led to a statistically significant and "clinically meaningful" survival improvement in…

A new hub at Newcastle University will benefit cancer patients and researchers

A dual cannabinoid agonist drug candidate is being investigated for its potential in treating wasting syndrome in cancer patients.

Some 77% of patients saw their tumours shrink, 8% saw them completely disappear, and 69% saw partial shrinkage of their tumours.

Some 77% of patients saw their tumours shrink, 8% saw them completely disappear, and 69% saw partial shrinkage of their tumours.

Some 77% of patients saw their tumours shrink, 8% saw them completely disappear, and 69% saw partial shrinkage of their tumours.

Some 77% of patients saw their tumours shrink, 8% saw them completely disappear, and 69% saw partial shrinkage of their tumours.

Treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed EGFR-mutated advanced non-small…

Legalizing marijuana for medical or recreational purposes is “significantly associated with reduced opioid use among patients diagnosed with cancer,” according to a new federally funded study published by the American Medical Association …

An alliance of scientists at the Broad Institute and Bayer Pharmaceuticals have developed a drug candidate, sevabertinib, that could be a new treatment for a group of lung cancer patients who have few options today.

In recent research, treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed EGFR…

Researchers appear to have found a solution for younger patients who do not respond well enough to tamoxifen

In oncology, progress is often described in cautious terms: a few months’ extra survival, a slightly improved quality of life, a percentage-point increase in remission. These steps matter, but they also reflect an industry built around…